|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
CARBAMAZEPINE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
BENZODIAZEPINES DOSE IS TO BE INCREASED TO ACHIEVE SEDATION ON CONCOMITANT USE. DOSE SHOULD BE REDUCED ONCE THEOPHYLLINE IS WITHDRAWN OTHERWISE TOXICITY APPEARS
|
BENZODIAZEPINES DOSE IS TO BE INCREASED TO ACHIEVE SEDATION ON CONCOMITANT USE. DOSE SHOULD BE REDUCED ONCE THEOPHYLLINE IS WITHDRAWN OTHERWISE TOXICITY APPEARS
|
BENZODIAZEPINES CAN CAUSE RESPIRATORY DEPRESSION BUT DOSE OF BARBITURATE IS DECREASED
|
BENZODIAZEPINES CAN CAUSE RESPIRATORY DEPRESSION BUT DOSE OF BARBITURATE IS DECREASED
|
BENZODIAZEPINES CAN CAUSE RESPIRATORY DEPRESSION BUT DOSE OF BARBITURATE IS DECREASED
|
BENZODIAZEPINES CAN CAUSE RESPIRATORY DEPRESSION BUT DOSE OF BARBITURATE IS DECREASED
|
BENZODIAZEPINES CAN CAUSE RESPIRATORY DEPRESSION BUT DOSE OF BARBITURATE IS DECREASED
|
BENZODIAZEPINES CAN CAUSE RESPIRATORY DEPRESSION BUT DOSE OF BARBITURATE IS DECREASED
|
BENZODIAZEPINES CAN CAUSE RESPIRATORY DEPRESSION BUT DOSE OF BARBITURATE IS DECREASED
|
CO-ADMINISTRATION MAY INCREASE CHANCES OF POSTOPERATIVE RESPIRATORY DEPRESSION OR ENHANCE IT
|
MAY POTENTIATE THE ACTION OF DIAZEPAM
|
CO-ADMINISTRATION OF DIAZEPAM AS AN ADJUNCT IN TREATING CONVULSIVE DISORDERS RESULTS IN POSSIBILITY OF AN INCREASE IN THE FREQUENCY AND/OR SEVERITY OF GRAND MAL SEIZURES WHICH MAY REQUIRE AN INCREASE IN THE DOSAGE OF STANDARD ANTICONVULSANT AGENT
|
CO-ADMINISTRATION OF DIAZEPAM AS AN ADJUNCT IN TREATING CONVULSIVE DISORDERS RESULTS IN POSSIBILITY OF AN INCREASE IN THE FREQUENCY AND/OR SEVERITY OF GRAND MAL SEIZURES WHICH MAY REQUIRE AN INCREASE IN THE DOSAGE OF STANDARD ANTICONVULSANT AGENT
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
CLOBAZAM CONCURRENT ADMINISTRATION WITH THE DRUG LEADS TO REDUCED CLEARANCE OF CLOBAZAM, HENCE THE DOSE SHOULD BE REDUCED TO ONE THIRD
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
ERYTHROMYCIN DECREASES CLEARANCE OF BENZODIAZEPINES, THUS INCREASE THE PHARMACOLOGIC EFFECT OF THE DRUG SO THEIR DOSE SHOULD BE REDUCED TO 1/3
|
ERYTHROMYCIN DECREASES CLEARANCE OF BENZODIAZEPINES, THUS INCREASE THE PHARMACOLOGIC EFFECT OF THE DRUG SO THEIR DOSE SHOULD BE REDUCED TO 1/3
|
ERYTHROMYCIN DECREASES CLEARANCE OF BENZODIAZEPINES, THUS INCREASE THE PHARMACOLOGIC EFFECT OF THE DRUG SO THEIR DOSE SHOULD BE REDUCED TO 1/3
|
ERYTHROMYCIN DECREASES CLEARANCE OF BENZODIAZEPINES, THUS INCREASE THE PHARMACOLOGIC EFFECT OF THE DRUG SO THEIR DOSE SHOULD BE REDUCED TO 1/3
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
PHENOBARBITONE ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
VALPROIC ACID ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
VALPROIC ACID ENHANCES DRUG METABOLISM HENCE DECREASED SERUM LEVELS OF THE DRUG HAVE BEEN OBSERVED
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
INCREASED SEDATIVE EFFECT
|
MEPHENESIN CNS MUSCLE RELAXANT EFFECT IS ENHANCED BY THE DRUG
|
PROBENECID INCREASES THE HALF LIFE OF THE DRUG
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
ORAL CONTRACEPTIVES INCREASE ITS PLASMA CONCENTRATION BY 15-20%
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|
MAY INCREASE DROWSINESS EFFECT
|